Molbio Diagnostics’ Truenat platform has evolved into a comprehensive multi-disease diagnostic solution, with over 30 validated and regulatory-approved assays now available. In an interview with Financial Express, Chandrasekhar Nair, Co-Founder and CTO, highlighted Truenat’s role in expanding access to molecular diagnostics for diseases like TB, COVID-19, Hepatitis, Dengue, Malaria, and more. Engineered for portability, ruggedness, and minimal infrastructure dependence, Truenat enables fast, point-of-care testing even in remote areas. The company continues to develop new tests for emerging diseases and remains committed to strengthening early detection capabilities across healthcare systems worldwide.
